Literature for firibastat (M01.003 inhibitor)

(Topics flags: T Target, I Inhibitor. To select only the references relevant to a single topic, click the link above. See explanation.)

2020
1. Marc,Y., Boitard,S.E., Balavoine,F., Azizi,M. and Llorens-Cortes,C.
   Targeting brain aminopeptidase A: a new strategy for the treatment of hypertension and heart failure
   Can J Cardiol36, 721-731. PubMed  Europe PubMed DOI  I
2019
2. Azizi,M., Courand,P.Y., Denolle,T., Delsart,P., Zhygalina,V., Amar,L., Lantelme,P., Mounier-Vehier,C., de Mota,N., Balavoine,F. and Llorens-Cortes,C.
   A pilot double-blind randomized placebo-controlled crossover pharmacodynamic study of the centrally active aminopeptidase A inhibitor, firibastat, in hypertension
   J Hypertens37, 1722-1728. PubMed  Europe PubMed DOI  I
3. Keck,M., de Almeida,H., Compere,D., Inguimbert,N., Flahault,A., Balavoine,F., Roques,B. and Llorens-Cortes,C.
   NI956/QGC006, a Potent orally active, brain-penetrating aminopeptidase A inhibitor for treating hypertension
   Hypertension73, 1300-1307. PubMed  Europe PubMed DOI  I
2017
4. Couvineau,P., de Almeida,H., Maigret,B., Llorens-Cortes,C. and Iturrioz,X.
   Involvement of arginine 878 together with Ca2+ in mouse aminopeptidase A substrate specificity for N-terminal acidic amino-acid residues
   PLoS ONE12, e0184237-e0184237. PubMed  Europe PubMed DOI  I
2016
5. Hmazzou,R., Flahault,A., Marc,Y. and Llorens-Cortes,C.
   [OP.6D.03] Mode of action of RB150, an aminopeptidase A inhibitor prodrug as a centrally-acting antihypertensive agent in DOCA-salt hypertensive rats
   J Hypertens34 Suppl 2, e75-e75. DOI  I
2014
6. Gao,J., Marc,Y., Iturrioz,X., Leroux,V., Balavoine,F. and Llorens-Cortes,C.
   A new strategy for treating hypertension by blocking the activity of the brain renin-angiotensin system with aminopeptidase A inhibitors
   Clin Sci (Lond)127, 135-148. PubMed  Europe PubMed DOI  I
2012
7. Marc,Y., Gao,J., Balavoine,F., Michaud,A., Roques,B.P. and Llorens-Cortes,C.
   Central antihypertensive effects of orally active aminopeptidase A inhibitors in spontaneously hypertensive rats
   Hypertension60, 411-418. PubMed  Europe PubMed DOI  I
2008
8. Bodineau,L., Frugiere,A., Marc,Y., Claperon,C. and Llorens-Cortes,C.
   Aminopeptidase A inhibitors as centrally acting antihypertensive agents
   Heart Fail Rev13, 311-319. PubMed  Europe PubMed DOI  T  I
9. Bodineau,L., Frugiere,A., Marc,Y., Inguimbert,N., Fassot,C., Balavoine,F., Roques,B. and Llorens-Cortes,C.
   Orally active aminopeptidase A inhibitors reduce blood pressure: a new strategy for treating hypertension
   Hypertension51, 1318-1325. PubMed  Europe PubMed DOI  I
10. de Mota,N., Iturrioz,X., Claperon,C., Bodineau,L., Fassot,C., Roques,B.P., Palkovits,M. and Llorens-Cortes,C.
    Human brain aminopeptidase A: biochemical properties and distribution in brain nuclei
    J Neurochem106, 416-428. PubMed  Europe PubMed DOI  I
1994
11. Chauvel,E.N., Coric,P., Llorens-Cortes,C., Wilk,S., Roques,B.P. and Fournie-Zaluski,M.C.
    Investigation of the active site of aminopeptidase A using a series of new thiol-containing inhibitors
    J Med Chem37, 1339-1346. PubMed  Europe PubMed DOI  I
12. Chauvel,E.N., Llorens-Cortes,C., Coric,P., Wilk,S., Roques,B.P. and Fournie-Zaluski,M.C.
    Differential inhibition of aminopeptidase A and aminopeptidase N by new beta-amino thiols
    J Med Chem37, 2950-2957. PubMed  Europe PubMed  I